Counterpart Raises $50.0M Series C

LifeMine Therapeutics

LifeMine Therapeutics is a clinical-stage biopharmaceutical company pioneering Top-Down Drug DiscoveryTM, which leverages evolutionary insights from fungi to unearth next-generation precision medicines. LifeMine’s data-immersive platform integrates the latest advancements in human genetics and genomics, bioinformatics, machine learning and synthetic biology. LifeMine’s lead program, LIFE-001, is a novel, precision-engineered, long-acting calcineurin inhibitor being developed for multiple immunologic disorders and organ transplantation.

MiiHealth AI

MiiHealth AI is transforming outpatient care with agentic AI that automates patient intake and pre-visit data collection. Our multilingual AI conversations capture clinical histories autonomously before the provider enters the room—reducing administrative burden, minimizing burnout, and improving clinic efficiency. As providers spend up to 45% of their time on pre-visit admin, MiiHealth AI’s platform Mediiflow streamlines workflows while enhancing the patient experience. By freeing up provider time and accelerating care delivery, our platform gives over 120 minutes back to every provider, every day. Mediiflow isn’t just a tool—it’s the next step toward more efficient, human-centered outpatient operations. MiiHealth integrates real-time agentic AI by voice with clinical workflows via DAINA, collecting clinical histories with empathetic and natural conversation, in the patient's native language, before provider visits. DAINA engages patients in natural, multilingual conversations, asking the same repetitive questions a provider would have to—symptoms, history, medications—and adapts in real time based on responses. She then generates a structured clinical note to best prep the provider for the visit. By automating this process, DAINA reduces administrative burden, improves documentation quality, and allows clinicians to focus on what matters most—the patient. This thoughtful integration of AI enhances efficiency, personalization, and access in healthcare.